CircUGP2 Suppresses Intrahepatic Cholangiocarcinoma Progression via p53 Signaling Through Interacting With PURB to Regulate ADGRB1 Transcription and Sponging miR‐3191‐5p
Advanced Science · 2024-10 · 11 (38)
DOI: 10.1002/advs.202402329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 09.08.2024. Verfasst von Rui Xiang Chen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medica…. Hauptthemen laut MEDLINE: Cholangiocarcinoma, RNA, Circular, Tumor Suppressor Protein p53, Disease Progression. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer and its prognosis remains poor. Although growing numbers of studies have verified the involvement of circular RNAs (circRNAs) in various cancer types, their specific functions in ICC remain elusive. Herein, a circRNA, circUGP2 is identified by circRNA sequencing, which is downregulated in ICC tissues and correlated with patients’ prognosis. Moreover, circUGP2 overexpression suppresses tumor progression in vitro and in vivo. Mechanistically, circUGP2 functions as a transcriptional co‐activator of PURB over the expression of ADGRB1. It can also upregulate ADGRB1 expression by sponging miR‐3191‐5p. As a result, ADGRB1 prevents MDM2‐mediated p53 polyubiquitination and thereby activates p53 signaling to inhibit ICC progression. Based on these findings, circUGP2 plasmid is encapsulated into a lipid nanoparticle (LNP) system, which has successfully targeted tumor site and shows superior anti‐tumor effects. In summary, the present study has identified the role of circUGP2 as a tumor suppressor in ICC through regulating ADGRB1/p53 axis, and the application of LNP provides a promising translational strategy for ICC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key Laboratory of Living Donor Liver Transplantation (…
- School of Medicine, Southeast University, Nanjing, Jiangsu, 210009, China.
- The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, 214023, China.
ORCID-Profile: Xiang Cheng Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Chen, R. X., Liu, S. C., Kan, X. C., Wang, Y. R., Wang, J. F., Wang, T. L., Li, C., Jiang, W. J., Chen, Y. A. L., Zhou, T., Fan, S. L., Chang, J., Xu, X., Shi, K. H., Zhang, Y. D., Wu, M. Y., Yu, Y., Li, C. X., & Li, X. C. (2024). CircUGP2 Suppresses Intrahepatic Cholangiocarcinoma Progression via p53 Signaling Through Interacting With PURB to Regulate ADGRB1 Transcription and Sponging miR‐3191‐5p. Advanced Science, 11(38). https://doi.org/10.1002/advs.202402329
Vancouver
Chen RX, Liu SC, Kan XC, Wang YR, Wang JF, Wang TL, et al. CircUGP2 Suppresses Intrahepatic Cholangiocarcinoma Progression via p53 Signaling Through Interacting With PURB to Regulate ADGRB1 Transcription and Sponging miR‐3191‐5p. Advanced Science. 2024;11(38). doi:10.1002/advs.202402329
BibTeX
@article{Chen2024,
author = {Chen, Rui Xiang and Liu, Shuo Chen and Kan, Xue Chun and Wang, Yi Rui and Wang, Ji Fei and Wang, Tian Lin and Li, Chang and Jiang, Wang Jie and Chen, Yan An Lan and Zhou, Tao and Fan, Shi Long and Chang, Jiang and Xu, Xiao and Shi, Kuang Heng and Zhang, Yao Dong and Wu, Ming Yu and Yu, Yue and Li, Chang Xian and Li, Xiang Cheng},
title = {CircUGP2 Suppresses Intrahepatic Cholangiocarcinoma Progression via p53 Signaling Through Interacting With PURB to Regulate ADGRB1 Transcription and Sponging miR‐3191‐5p},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {38},
doi = {10.1002/advs.202402329}
}
EUVIMED